Viridian Therapeutics, Inc. (VRDN)
26.98
-0.86
(-3.09%)
USD |
NASDAQ |
Mar 20, 16:00
26.99
+0.01
(+0.04%)
After-Hours: 20:00
Viridian Therapeutics Market Cap : 2.758B for March 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 22.34M |
| Plus Therapeutics, Inc. | 44.22M |
| Nutriband, Inc. | 44.86M |
| Immunovant, Inc. | 4.677B |
| Definium Therapeutics, Inc. | 1.834B |
Market Cap Related Metrics
| PS Ratio | 32.28 |
| PEG Ratio | -8.360 |
| Price to Book Value | 4.673 |
| Price | 26.98 |
| Earnings Yield | -14.11% |
| PEGY Ratio | -8.360 |